Guinness Asset Management LTD Sells 747 Shares of Agilent Technologies, Inc. $A

Guinness Asset Management LTD decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 19.2% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 3,142 shares of the medical research company’s stock after selling 747 shares during the period. Guinness Asset Management LTD’s holdings in Agilent Technologies were worth $367,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Sunbelt Securities Inc. boosted its holdings in shares of Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock worth $30,000 after buying an additional 192 shares during the period. Whipplewood Advisors LLC raised its stake in Agilent Technologies by 286.2% in the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock worth $29,000 after purchasing an additional 186 shares in the last quarter. Wood Tarver Financial Group LLC acquired a new stake in Agilent Technologies in the 4th quarter worth about $34,000. Stone House Investment Management LLC acquired a new stake in Agilent Technologies in the 1st quarter worth about $30,000. Finally, Opal Wealth Advisors LLC acquired a new stake in Agilent Technologies in the 1st quarter worth about $31,000.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the business’s stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the sale, the chief executive officer directly owned 37,448 shares of the company’s stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Agilent Technologies Trading Up 2.2%

Shares of Agilent Technologies stock opened at $126.88 on Friday. The firm has a market capitalization of $35.97 billion, a PE ratio of 29.78, a price-to-earnings-growth ratio of 3.86 and a beta of 1.24. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm’s 50 day moving average is $119.72 and its 200 day moving average is $116.07. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Analyst Ratings Changes

A has been the subject of several analyst reports. TD Cowen lifted their price objective on shares of Agilent Technologies to $150.00 and gave the stock a “buy” rating in a research note on Thursday, May 29th. Wall Street Zen cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Leerink Partners lifted their price objective on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research note on Friday, May 30th. Evercore ISI dropped their price objective on shares of Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating for the company in a research note on Thursday, August 28th. Finally, Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $135.00 to $140.00 and gave the company an “overweight” rating in a research report on Thursday, August 28th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $139.25.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.